233 related articles for article (PubMed ID: 29051620)
1. Antimicrobial peptide-loaded gold nanoparticle-DNA aptamer conjugates as highly effective antibacterial therapeutics against Vibrio vulnificus.
Lee B; Park J; Ryu M; Kim S; Joo M; Yeom JH; Kim S; Park Y; Lee K; Bae J
Sci Rep; 2017 Oct; 7(1):13572. PubMed ID: 29051620
[TBL] [Abstract][Full Text] [Related]
2. Gold nanoparticle-DNA aptamer conjugate-assisted delivery of antimicrobial peptide effectively eliminates intracellular Salmonella enterica serovar Typhimurium.
Yeom JH; Lee B; Kim D; Lee JK; Kim S; Bae J; Park Y; Lee K
Biomaterials; 2016 Oct; 104():43-51. PubMed ID: 27424215
[TBL] [Abstract][Full Text] [Related]
3. Gold nanoparticle-DNA aptamer-assisted delivery of antimicrobial peptide effectively inhibits Acinetobacter baumannii infection in mice.
Park J; Shin E; Yeom JH; Choi Y; Joo M; Lee M; Kim JH; Bae J; Lee K
J Microbiol; 2022 Jan; 60(1):128-136. PubMed ID: 34964948
[TBL] [Abstract][Full Text] [Related]
4. Genistein inhibits Vibrio vulnificus adhesion and cytotoxicity to HeLa cells.
Oh DR; Kim JR; Kim YR
Arch Pharm Res; 2010 May; 33(5):787-92. PubMed ID: 20512479
[TBL] [Abstract][Full Text] [Related]
5. Study of the Antimicrobial Activity of Tilapia Piscidin 3 (TP3) and TP4 and Their Effects on Immune Functions in Hybrid Tilapia (Oreochromis spp.).
Pan CY; Tsai TY; Su BC; Hui CF; Chen JY
PLoS One; 2017; 12(1):e0169678. PubMed ID: 28085905
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antimicrobial activity of water-soluble chitosan oligosaccharides against Vibrio vulnificus.
Lee BC; Kim MS; Choi SH; Kim KY; Kim TS
Int J Mol Med; 2009 Sep; 24(3):327-33. PubMed ID: 19639224
[TBL] [Abstract][Full Text] [Related]
7. Insights into the antibacterial and immunomodulatory functions of tilapia hepcidin (TH)2-3 against Vibrio vulnificus infection in mice.
Pan CY; Lee SC; Rajanbabu V; Lin CH; Chen JY
Dev Comp Immunol; 2012 Jan; 36(1):166-73. PubMed ID: 21756935
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo anti-Vibrio vulnificus activity of psammaplin A, a natural marine compound.
Lee BC; Lee A; Jung JH; Choi SH; Kim TS
Mol Med Rep; 2016 Sep; 14(3):2691-6. PubMed ID: 27431807
[TBL] [Abstract][Full Text] [Related]
9. Protective mechanism of curcumin against Vibrio vulnificus infection.
Na HS; Cha MH; Oh DR; Cho CW; Rhee JH; Kim YR
FEMS Immunol Med Microbiol; 2011 Dec; 63(3):355-62. PubMed ID: 22092562
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection.
Chiang SR; Tang HJ; Chang PC; Cheng KC; Ko WC; Chen CH; Chuang YC
J Microbiol Immunol Infect; 2007 Apr; 40(2):123-33. PubMed ID: 17446960
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificus.
Tang HJ; Chen CC; Lai CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
J Microbiol Immunol Infect; 2018 Feb; 51(1):76-81. PubMed ID: 27260781
[TBL] [Abstract][Full Text] [Related]
12. Vibrio parahaemolyticus and Vibrio vulnificus Recovered from Oysters during an Oyster Relay Study.
Elmahdi S; Parveen S; Ossai S; DaSilva LV; Jahncke M; Bowers J; Jacobs J
Appl Environ Microbiol; 2018 Feb; 84(3):. PubMed ID: 29150510
[No Abstract] [Full Text] [Related]
13. DIDS inhibits Vibrio vulnificus cytotoxicity by interfering with TolC-mediated RtxA1 toxin secretion.
Guo RH; Gong Y; Kim SY; Rhee JH; Kim YR
Eur J Pharmacol; 2020 Oct; 884():173407. PubMed ID: 32735984
[TBL] [Abstract][Full Text] [Related]
14. A helix-PXXP-helix peptide with antibacterial activity without cytotoxicity against MDRPA-infected mice.
Lee JK; Park SC; Hahm KS; Park Y
Biomaterials; 2014 Jan; 35(3):1025-39. PubMed ID: 24176194
[TBL] [Abstract][Full Text] [Related]
15. Cefazolin plus minocycline against a clinical isolate of Vibrio vulnificus: in vitro and animal studies.
Tang HJ; Ko WC; Chuang YC; Chen CC; Chiang SR
Jpn J Infect Dis; 2010 Jan; 63(1):16-8. PubMed ID: 20093756
[TBL] [Abstract][Full Text] [Related]
16.
Kim SE; Kim HK; Choi SM; Yu Y; Kim UJ; Darboe KS; Kang SJ; Park KH; Kang G; Kim YR; Rhee JH; Jung SI; Jang HC
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332060
[TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis.
Jang HC; Choi SM; Kim HK; Kim SE; Kang SJ; Park KH; Ryu PY; Lee TH; Kim YR; Rhee JH; Jung SI; Choy HE
PLoS One; 2014; 9(6):e101118. PubMed ID: 24978586
[TBL] [Abstract][Full Text] [Related]
18. Gold nanoparticle-DNA aptamer composites as a universal carrier for in vivo delivery of biologically functional proteins.
Ryou SM; Yeom JH; Kang HJ; Won M; Kim JS; Lee B; Seong MJ; Ha NC; Bae J; Lee K
J Control Release; 2014 Dec; 196():287-94. PubMed ID: 25450403
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of polygoni cuspidati radix and emodin on Vibrio vulnificus cytotoxicity and infection.
Kim JR; Oh DR; Cha MH; Pyo BS; Rhee JH; Choy HE; Oh WK; Kim YR
J Microbiol; 2008 Dec; 46(6):737-43. PubMed ID: 19107405
[TBL] [Abstract][Full Text] [Related]
20. Use of a marker plasmid to examine differential rates of growth and death between clinical and environmental strains of Vibrio vulnificus in experimentally infected mice.
Starks AM; Bourdage KL; Thiaville PC; Gulig PA
Mol Microbiol; 2006 Jul; 61(2):310-23. PubMed ID: 16856938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
